Randomized Trialhigh evidence

Carbocisteine or Hypertonic Saline for Acute Respiratory Failure.

The New England journal of medicine·June 10, 2026·PMID 42267821

Why it matters

Mucoactive agents are commonly used in the ICU for secretion management despite limited evidence. This large, rigorous trial provides clear evidence that these interventions do not improve outcomes and cause harm, which should prompt emergency physicians and intensivists to reconsider their use in mechanically ventilated patients.

Infographic summary of Carbocisteine or Hypertonic Saline for Acute Respiratory Failure.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled